Drug recall
Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences…
FDA recall event 95399 · Class I · Gilead Sciences, Inc.
Key facts
| Event ID | 95399 |
|---|---|
| Recall numbers | D-0005-2025 |
| Recalling firm | Gilead Sciences, Inc. |
| Product type | Drugs |
| Products | Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2 |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Presence of Particulate Matter: Presence of glass particle. |
| Initiation date | Sep 19, 2024 |
| Report date | Oct 9, 2024 |
| Termination date | Jul 29, 2025 |
| City | Foster City |
| State | CA |
| Country | United States |
| FEI number | 1000523075 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: